• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Carcinoma, Papillary

Carcinoma, Papillary - 18 Studies Found

Not yet recruiting : Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
:
  • Adenoid Cystic Carcinoma
  • Adnexal Carcinoma
  • Apocrine Carcin
    : 2016-11-30
    :
    • Other: Laboratory Biomarker Analysis

Active, not recruiting : Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
:
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Seromucinous Carcinoma
  • Drug: Everolimus Given PO

Active, not recruiting : Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
:
  • Deleterious BRCA1 Gene Mutation
  • Deleterious BRCA2 Gene Mutation
  • Drug: Cediranib Maleate Given

Completed : Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma
: Thyroid Papillary Carcinoma
: 2015-12-13
:
  • Procedure: surgery:BCND(bilateral central lymph node dissectio

Completed : Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients
: Thyroid Neoplasms
: 2010-04-29
: Drug: Administration of 131 iodine 100 mCi 131 iodine irradiation
Recruiting : Comparison Between the Axillary Bilateral-breast Approach (ABBA) and Bilateral Axillo-breast Approach (BABA) for Robotic Thyroidectomy
:
  • Thyroid Papillary Carcinoma
  • Thyroidectomy

: 2016-05-02
:
  • Procedure: The Axillary Bilateral-breast Approach

Completed : A Gene Hunting Study for Familial Papillary Thyroid Cancer
: Thyroid
: 2016-05-12
Completed : Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
: Endometrial Cancer
: 2011-05-26
:
  • Drug: Carboplatin/Paclitaxel P

Completed : Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
:
  • Recurrent Thyroid Gland Carcinoma
  • Stage I Thyroid Gland Papillary Carc
    : 2007-11-16
    :
    • Other: Laboratory Biomarker Analysis

Completed : Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid
: Papillary Thyroid Cancer
: 2009-09-24
: Radiation: 99mTc-MIBI SPECT-CT 99mTc-MIBI SPECT-CT for abnormal cervical lymph node
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.